NDC 85237-1829-02 - Alka-Seltzer Original
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1829
- Requested NDC
- 85237-1829-02
- Package NDCs from labels
- 85237-1829-1, 85237-1829-0, 85237-1829-2, 85237-1829-3, 85237-1829-4, 85237-1829-6, 85237-1829-7, 85237-1829-02
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alka-Seltzer Original - Select Consumer Group | Select Consumer Group | 2026-05-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1829-1 | Alka-Seltzer Original | 1 in 1 BLISTER PACK | TABLET, EFFERVESCENT | 1 | 1 | |
| 85237-1829-1 | Alka-Seltzer Original | 2 in 1 POUCH | TABLET, EFFERVESCENT | 2 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Antacid Pain Relief Extra Strength | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walgreens | b60df498-07db-500b-e053-2a95a90aff6a | 2025-10-17 | Warnings | M013 R16CO5Y76E XF417D3PSL 8MDF5V39QO |
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | M013 1536675 R16CO5Y76E XF417D3PSL 8MDF5V39QO |
| Orphenadrine Citrate, Aspirin and Caffeine | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Atland Pharmaceuticals, LLC | 7776aae6-3cbd-4aed-9aac-4bed80339e27 | 2025-10-17 | Warnings, Adverse reactions | R16CO5Y76E |
| Xesso Neo | BENZOCAINE | PREMIUM NATURAL COSMETICS INC | 163f32cd-4e51-950a-e063-6394a90a4816 | 2025-10-17 | Warnings | M013 |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CHAIN DRUG MARKETING ASSOCIATION INC | 913d8bdb-7644-464c-b9a6-55387ff12059 | 2025-10-17 | Warnings | M013 |
| ORPHENGESIC FORTE | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Galt Pharmaceuticals, LLC | 5bc485db-9d96-4291-aaa3-2a96ebf3098a | 2025-10-16 | Warnings, Adverse reactions | R16CO5Y76E |
| Alka-Seltzer Hangover Relief | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | dc235b06-999e-221d-e053-2a95a90a0ce1 | 2025-10-16 | Warnings | M013 R16CO5Y76E |
| Orphenadrine Citrate, Aspirin and Caffeine | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Atland Pharmaceuticals, LLC | 61ca2af1-081c-411c-90ce-ec6d9e3157b2 | 2025-10-16 | Warnings, Adverse reactions | R16CO5Y76E |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 41386de5-5857-efab-e063-6294a90afd9c | 2025-10-15 | Warnings | M013 R16CO5Y76E |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 4138d4c0-baa5-1f20-e063-6394a90a788f | 2025-10-15 | Warnings | M013 R16CO5Y76E |
| TEXACLEAR PAIN RELIEVER | CAFFEINE, CHOLINE SALICYLATE | GM Pharmaceuticals, INC | 065bd10c-3bcf-486f-a49c-40544127007f | 2025-10-15 | Warnings | M013 |
| acetaminophen | ACETAMINOPHEN | Rite Aid Corporation | a8bb4f45-7a1a-4bf7-92ca-3afd508032f3 | 2025-10-09 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | Health Pharma USA LLC | b15a7dcb-f143-4aea-8850-d0aacbf709b6 | 2025-10-09 | Warnings | M013 |
| EQUATE SALINE PACKETS | NASAL CLEANING SALT | WALMART INC | 9e905ecb-d4d5-514a-e053-2a95a90adfbb | 2025-10-08 | Warnings | 8MDF5V39QO |
| EQUATE NETI POT SINUS WASH | NASAL WASH | WALMART INC | 9e90c1c1-4dcd-106e-e053-2995a90afd15 | 2025-10-08 | Warnings | 8MDF5V39QO |
| GURUNANDA NASAL SALINE | NASAL WASH | GURUNANDA LLC | 2b4d78ae-b587-6dfe-e063-6394a90a8876 | 2025-10-08 | Warnings | 8MDF5V39QO |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walgreens | f2eb9575-d527-44c7-aa5e-efabfd9a0278 | 2025-10-07 | Warnings | M013 R16CO5Y76E |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | CHAIN DRUG MARKETING ASSOCIATION INC | bbc704e5-79f6-4c72-846b-cc30c5c43cb4 | 2025-10-07 | Warnings | M013 |
| Mitochondria PRO | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 8c3e961d-bc33-40cd-a282-a4fe5aa3f0ad | 2025-10-06 | Warnings | XF417D3PSL |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Rising Pharma Holdings, Inc. | 50f72713-50f5-4bab-9e96-b9fa73c9df1f | 2025-10-06 | Warnings | M013 R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.